- Published at
- by manilatimes.net
positive
positive
NGM Bio Announces Appointment of Wendy Yeh, M.D. as Chief Medical Officer
**media[531546,531547]**
News for NGM Biopharmaceuticals, Inc. (NGM)
- Published at
- by globenewswire.com
mixedmixedGeographic Atrophy (GA) Market Size to Hit USD 50.0 Billion by 2032 with a 8.6% CAGR – SNS Insider
Robust Growth in the Geographic Atrophy Market Driven by Aging Population and Technological Advances...- Published at
- by globenewswire.com
mixedmixedPharmaceutical Intermediates Market Size To Reach USD 14.0 Billion By 2033, at 13.4% CAGR: Insights by Dimension Market Research
Advancements and Projections in the Pharmaceutical Intermediates Market: Insights, Trends, Opportunities, and Recent Developments...- Published at
- by globenewswire.com
positivepositiveNGM Bio Announces Closing of Tender Offer
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (“NGM Bio”) (Nasdaq: NGM), a biotechnology company focused on discovering...- Published at
- by globenewswire.com
mixedmixedCirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
The rise in the number of people suffering from cirrhosis can be attributed to rapidly changing lifestyles such as an increase in alcohol consumption and...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI -March 22, 2024 at 06:59 pm EDT
NEW YORK, March 22, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...- Published at
- by globenewswire.com
positivepositiveKuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm
Kuehn Law investigates potential claims related to proposed mergers of NGM, CTLT, SDPI, and HRT. Shareholders urged to contact for more info....- Published at
- by globenewswire.com
positivepositiveSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, NGM
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
neutralneutralNGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 19, 2024 -- NGM Biopharmaceuticals, Inc. , a biotechnology company focused on discovering and developing transformative therapeutics for patients, today...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE -March 18, 2024 at 10:54 pm EDT
NEW YORK, March 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...- Published at
- by benzinga.com
mixedmixedWhy Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Antelope Ent Hldgs (NASDAQ:AEHL), Aclarion (NASDAQ:ACON)
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.- Published at
- by prnewswire.com
mixedmixedLiver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight
/PRNewswire/ -- DelveInsight's Liver Cirrhosis Market Insights report includes a comprehensive understanding of current treatment practices, liver cirrhosis...- Published at
- by globenewswire.com
mixedmixedMesothelioma Clinical Trials Pipeline Analysis: 50+ Companies are Working to Improve the Treatment Space | DelveInsight
The prevalence of mesothelioma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence...- Published at
- by globenewswire.com
mixedmixedProthena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors
DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust...- Published at
- by globenewswire.com
mixedmixedAdvanced Cervical Cancer Clinical Trial Pipeline Analysis Research Report 2022 by DelveInsight
As per DelveInsight, recent advances in Cervical Cancer have provided new options for treating patients with advanced forms of the disease, fulfilling a...- Published at
- by markets.businessinsider.com
mixedmixed60 Biggest Movers From Friday
Gainers IVERIC bio, Inc. (NASDAQ:ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its ...- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja...TPMR.MUTPMR.FTPMR.BETNXPSLNPRLDPRAHPMVPPGENPBYIOTICOCGNNGMMRNA.MXMRNAMASI.MXMASILIFEJAGXIMU.MUIMU.FIMU.DEIMU.BEIMGNIMABI5X.FGRTSGBIOFLGT.MXFLGTFATEF6T.FF6T.BEF2KA.FEO7.MUEO7.FEO7.BEENDPEIDXDMACCRISCMPIC6K.FBX2.MUBX2.FBX2.BEBTAIAIO.MUAIO.FAIO.BEABMD8PH.SG8PH.MU8PH.F8PH.BE7OT.MU7OT.F7F0.F7F0.BE471A.F471A.BE3M4.MU3M4.F3M4.BE2JQ.SG2JQ.MU2JQ.F2H51.F2H51.BE1JA2.SG1JA2.F1JA2.BE0VY.F0QF.SG0QF.MU0QF.F0QF.BE0PB.F0PB.BEZSANXTLBVVOSVTGNTCONT051.FT051.BEICPTI4P.MUI4P.FI4P.BEH2K2.SGH2K2.FH2K2.BECUSA.FCUSA.BECLPTCERCBNGO.MXBNGOBBIOBASIAVIRARVN2Y3.MU2Y3.BE2CL.MU2CL.F0ZPN.SG0ZPN.F0ZPN.BEUTHRUTH.SGUTH.MUUTH.FUTH.BEMYOVMRSNFDMTCALAAPRE71M.SG71M.F71M.BE2CB.F2CB.BE0M4.F0M4.BE